293 Pill - brown oval, 13mm
Pill with imprint 293 is Brown, Oval and has been identified as Verapamil Hydrochloride Extended Release 180 mg. It is supplied by Glenmark Generics Inc., USA.
Verapamil is used in the treatment of Arrhythmia; Angina; High Blood Pressure; Headache; Migraine and belongs to the drug classes calcium channel blocking agents, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Verapamil 180 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 293
Verapamil Hydrochloride Extended Release
- Imprint
- 293
- Strength
- 180 mg
- Color
- Brown
- Size
- 13.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Calcium channel blocking agents, Group IV antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Glenmark Generics Inc., USA
- National Drug Code (NDC)
- 68462-0293
- Inactive Ingredients
-
silicon dioxide,
sodium alginate,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
povidone,
titanium dioxide,
polyethylene glycol 400,
ferric oxide yellow,
ferric oxide red,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Related images for "293"
More about verapamil
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (180)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: calcium channel blocking agents
- Breastfeeding
- En español
Patient resources
- Verapamil drug information
- Verapamil oral/injection
- Verapamil (Intravenous) (Advanced Reading)
- Verapamil (Oral) (Advanced Reading)
- Verapamil Immediate-Release Tablets
Other brands
Calan, Calan SR, Verelan, Isoptin SR, ... +2 more
Professional resources
- Verapamil monograph
- Verapamil (FDA)
- Verapamil Extended Release Capsules (FDA)
- Verapamil Extended Release Tablets (FDA)
- Verapamil Hydrochloride PM (FDA)
Other brands
Calan, Calan SR, Verelan, Verelan PM
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
